Compugen in the NEWS
Compugen (CGEN) offered its fourth Quarter and full year 2023 results yesterday, which we yearned to learn about for many reasons. These reasons include learning about the outcome of the Company’s  discovered targets and its created products that would treat the targeted cancers.

For those who have no clue about Compugen, the following is the information needed . . .